<DOC>
	<DOCNO>NCT01139619</DOCNO>
	<brief_summary>Lung cancer one deadly type cancer lead cause death cancer Sweden . Five year survival 10 % men 15 % woman . Approximately 3300 individual Sweden diagnose year incidence adenocarcinoma increase . Lung cancer patient great extent currently diagnose exfoliative cytology . However , new drug lead personalized treatment demand specific classification tumour type . Today EGFR mutation status become important factor decide treatment strategy patient Non-Small Cell Lung cancer . Sufficient tumour material must available EGFR mutation status test . Core needle biopsy one way obtain quantity material need test mutation status . The portion patient core needle biopsy believe vary greatly hospital Sweden , difference 20 % 70 % assume , yet confirm study . This study investigate current situation procedure patient diagnose lung cancer . The result use describe possible adverse event connect procedure possibly contribute development good decision tool use decide core needle biopsy perform . More therapeutical target similar problem likely developed future . An investigation current quality procedure diagnose lung cancer biopsy facilitate future diagnose lung cancer ensure personalize treatment offer patient .</brief_summary>
	<brief_title>A Retrospective Study Investigate Current Situation Biopsy Testing Swedish Inoperable Non Small Cell Lung Cancer ( NSCLC ) Patients</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Diagnosis code C34 ( ICD10 ) . Inoperable lung cancer . Diagnosis lung cancer make 20100531 20090601 . Diagnosis code C34.9b . Diagnosis code C34.9h .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Biopsy Mapping</keyword>
	<keyword>Non small cell lung cancer</keyword>
	<keyword>NSCLC</keyword>
	<keyword>Lung cancer diagnosis</keyword>
	<keyword>Retrospective</keyword>
	<keyword>Inoperable Non Small Cell Lung Cancer</keyword>
</DOC>